Recent Company News

• 08:10 PM ET Aug 27, 2026
  

  BARDA's Project BioShield exercises $36.9M (~JPY5.88B) procurement option to procure Fetroja (¥2915.0000, +5.5)

• 08:04 AM ET Aug 27, 2026
  

  Verrica Pharmaceuticals completes enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH for the Treatment of Common Warts, with Topline Data Expected Q1 2027 ($4.91, 0.00)

• 03:42 PM ET Aug 25, 2026
  

  FDA approves Tivicay PD to treat HIV in newborns

• 09:11 PM ET Aug 04, 2026
  

  StreetAccount Asia Macro Headlines

• 06:13 AM ET Aug 03, 2026
  

  Transcript Intelligence: Shionogi & Co. Q1 Earnings Guidance

• 06:13 AM ET Aug 03, 2026
  

  Transcript Intelligence: Shionogi & Co. Q1 Earnings Themes

• 06:13 AM ET Aug 03, 2026
  

  Transcript Intelligence: Shionogi & Co. Q1 Earnings Q&A

• 02:50 AM ET Aug 03, 2026
  

  StreetAccount Metrics Recap - Shionogi & Co. Q1 Earnings (¥2898.5000, 0)

• 02:39 AM ET Aug 03, 2026
  

  Shionogi & Co. reports Q1 net income attributable ¥97.70B vs FactSet ¥44.59B [4 est, ¥38.84-51.10B] (¥2898.5000, 0)

• 08:31 PM ET Jul 30, 2026
  

  Apnimed, Inc. registers additional 2.3M shares - S-1MEF